BofA/Merrill Lynch Upgrades Bio-Reference Laboratories (BRLI) to Buy
Tweet Send to a FriendGet Alerts BRLI Hot Sheet
Price: $31.15 +0.26%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 23 | New: 29
Trade BRLI Now!
BofA/Merrill Lynch upgraded Bio-Reference Laboratories (NASDAQ: BRLI) from Neutral to Buy.
For an analyst ratings summary and ratings history on Bio-Reference Laboratories click here. For more ratings news on Bio-Reference Laboratories click here.
Shares of Bio-Reference Laboratories closed at $21.71 yesterday, with a 52 week range of $11.41-$24.48.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Bio-Reference Laboratories click here. For more ratings news on Bio-Reference Laboratories click here.
Shares of Bio-Reference Laboratories closed at $21.71 yesterday, with a 52 week range of $11.41-$24.48.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- SunTrust Robinson Humphrey Upgrades VeriFone (PAY) to Buy
- Piper Jaffray Upgrades Thomson Reuters (TRI) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
